Hemas Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Hemas Holdings CEO'su Ravi Jayasekera, Mar2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0% doğrudan sahiptir ve bu hisselerin değeri LKR 10.02K dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.7 yıl ve 10 yıldır.

Anahtar bilgiler

Ravi Jayasekera

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	0.00002%
Yönetim ortalama görev süresi	2.7yrs
Yönetim Kurulu ortalama görev süresi	10yrs

Son yönetim güncellemeleri

Recent updates

CEO

Ravi Jayasekera

less than a year

Görev süresi

Mr. Ravi Jayasekera is Member of Management Board at Hemas Holdings PLC and serves as its Acting CEO since March 31, 2024 and served as its Chief People Officer until June 2024. Mr. Jayasekera was Vice Pre...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ravi Jayasekera	Acting CEO & Member of Management Board	less than a year	Veri yok	0.000020% LKR 10.0k
Moiz Rehmanjee	Group Chief Financial Officer	1.8yrs	Veri yok	Veri yok
Manamalabaduge Saman Fernando	MD of Hemas Pharm Pvt. Ltd. and Hemas Surgical & Diagnostics Pvt. Ltd. & Member of Mgmt Board	no data	Veri yok	Veri yok
Lakith Peiris	MD of Hemas Hospitals (Private) Limited & Member of Board of Management	9.6yrs	Veri yok	Veri yok
Rakesh Khosla	MD of Srilanka	no data	Veri yok	Veri yok
Asitha F. Samaraweera	MD of Atlas Axillia Company (Private) Limited & Member of Management Board	6yrs	Veri yok	Veri yok
Athapaththu Mudiyanselage Dinesh Athapaththu of Kadawatha	MD of Morison Limited & Member of Management Board	3.6yrs	Veri yok	Veri yok
Sabrina Esufally	MD of Hemas Manufacturing (Private) Limited & Member of Management Board	no data	Veri yok	0.043% LKR 21.7m
Rizny Faisal	Chief Strategy & Growth Officer and Member of Management Board	no data	Veri yok	Veri yok
Mushin Kitchilan	Member of Management Board & Director of Hemas Transportation (Private) Limited	no data	Veri yok	Veri yok
Chulanga Perera	Group Chief Technology & Transformation Officer	1.3yrs	Veri yok	Veri yok
Jeewantha Sanjeewa	Chief Risk & Control Officer	no data	Veri yok	Veri yok

2.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim: HHL.N0000 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.7 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Husein Esufally	Non-Executive Chairman	27.1yrs	Veri yok	0.38% LKR 192.3m
Murtaza Ali Abidhusein Esufally	Non-Independent Non-Executive Director	26.2yrs	Veri yok	0.098% LKR 48.9m
Imtiaz Abidhusein Esufally	Non-Executive Director	33.5yrs	Veri yok	0.35% LKR 175.0m
Abbasally Esufally	Non-Executive Director	15.7yrs	Veri yok	0.028% LKR 14.0m
Sumitha Anura Ekanayake	Non-Executive Independent Deputy Chairman	11.1yrs	Veri yok	Veri yok
Widanalage Ajith Fernando	Independent Non Executive Director	less than a year	Veri yok	Veri yok
Ranil Pathirana	Independent Non-Executive Director	1.8yrs	Veri yok	Veri yok
W. Thusitha Perera	Independent Non-Executive Director	no data	Veri yok	Veri yok
W. V. Supun Weerasinghe	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
Amitha Amaratunga	Independent Non-Executive Director	8.8yrs	Veri yok	Veri yok
Prabhash Subasinghe	Independent Non-Executive Director	2.8yrs	Veri yok	Veri yok

10.0yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: HHL.N0000 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 10 yıldır).

Hemas Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Non-Executive Director recently sold LK₨11m worth of stock

Hemas Holdings PLC, Annual General Meeting, Jun 27, 2024

Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO

Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023

Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023

Hemas Holdings PLC, Annual General Meeting, Jun 28, 2022

Recent updates

First half dividend increased to LK₨1.00

Second quarter 2025 earnings released: EPS: LK₨2.53 (vs LK₨2.04 in 2Q 2024)

Price target increased by 7.5% to LK₨105

First quarter 2025 earnings released: EPS: LK₨1.58 (vs LK₨1.83 in 1Q 2024)

Non-Executive Director recently sold LK₨11m worth of stock

Final dividend increased to LK₨3.00

Hemas Holdings PLC, Annual General Meeting, Jun 27, 2024

Price target decreased by 11% to LK₨97.37

Third quarter 2024 earnings released: EPS: LK₨3.72 (vs LK₨1.64 in 3Q 2023)

Second quarter 2024 earnings released: EPS: LK₨2.04 (vs LK₨1.93 in 2Q 2023)

Upcoming dividend of LK₨0.40 per share at 3.3% yield

Price target increased by 9.3% to LK₨112

Hemas Holdings Announces Resignation of Kasturi Chellaraja, Group CEO

Consensus EPS estimates fall by 17%

First quarter 2024 earnings released: EPS: LK₨1.83 (vs LK₨1.81 in 1Q 2023)

Upcoming dividend of LK₨1.95 per share at 3.4% yield

Hemas Holdings PLC (COSE:HHL.N0000) acquired remaining 24.9% stake in Atlas Axillia Co. (Pvt) Ltd from Nirmal Anrudha Madanayake for LKR 3.4 billion.

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 9.0% to LK₨78.50

Third quarter 2023 earnings released: EPS: LK₨1.64 (vs LK₨2.69 in 3Q 2022)

Hemas Holdings PLC Announces Board Appointments, Effective January 1, 2023

Hemas Holdings PLC Announces Executive Changes, Effective January 1, 2023

Second quarter 2023 earnings released: EPS: LK₨1.93 (vs LK₨1.58 in 2Q 2022)

Price target increased to LK₨74.25

Consensus revenue estimates increase by 11%

First quarter 2023 earnings released: EPS: LK₨1.81 (vs LK₨1.07 in 1Q 2022)

Upcoming dividend of LK₨1.95 per share

Hemas Holdings PLC, Annual General Meeting, Jun 28, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to LK₨79.08

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: EPS exceeds analyst expectations

Second quarter 2022 earnings released: EPS LK₨1.58 (vs LK₨2.33 in 2Q 2021)

Upcoming dividend of LK₨2.90 per share

Non-Executive Chairman recently bought LK₨180m worth of stock

Price target decreased to LK₨100

First quarter 2022 earnings released: EPS LK₨1.07 (vs LK₨0.45 in 1Q 2021)

Upcoming dividend of LK₨1.45 per share

Full year 2021 earnings released: EPS LK₨6.81 (vs LK₨2.07 in FY 2020)

Independent Director has left the company

New 90-day low: LK₨80.40

Third quarter 2021 earnings released: EPS LK₨2.30 (vs LK₨1.64 in 3Q 2020)

New 90-day high: LK₨105

New 90-day high: LK₨101

Eden Hotel Lanka PLC (COSE:EDEN.N0000) acquired 56.6% stake in Serendib Hotels PLC (COSE:SHOT.N0000) from Hemas Holdings PLC (COSE:HHL.N0000) for approximately LKR 790 million.

New 90-day high: LK₨90.00

Price target raised to LK₨80.90

New 90-day high: LK₨79.10

Second quarter 2021 earnings released: EPS LK₨2.16

Hemas Holdings PLC Announces Executive Changes

New 90-day high - LK₨65.10

First quarter earnings released

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş